TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

Rosen Law Firm is investigating potential securities claims against MoonLake Immunotherapeutics for allegedly making false or misleading statements about their Nanobody technology and its clinical benefits during the period of March 10, 2024 to September 29, 2025.

Insights
BACpP   neutral

Mentioned as previous employer of new executive, with no direct commentary about the bank's performance


MLTX   negative

The lawsuit alleges the company made false statements about their Nanobody technology's clinical benefits, suggesting potential misrepresentation of their product's capabilities to investors